ConCallIQ
Go Pro
UP
UPL Other 28 Apr 2026

UPL Ltd — Q4 FY26

UPL delivered a strong FY26 with revenue up 11% to ₹52,000 crore and EBITDA up 18%, driven by volume-led growth across all regions and platforms.

bullish high
Revenue ₹18,335 Cr +11%
EBITDA +18%
PAT ₹1,294 Cr +160%
EBITDA Margin 19% +100bps
Duration 142 min
Read Time 1 min read

✓ Verified against BSE filing

2-Min Summary

✦ AI-Generated from Full Transcript

UPL delivered a strong FY26 with revenue up 11% to ₹52,000 crore and EBITDA up 18%, driven by volume-led growth across all regions and platforms. Contribution margin expanded 220bps to 31.5% in crop protection, while net debt/EBITDA fell to 1.6x from 2.1x. The company provided a Q1 FY27 guidance of 10-14% revenue growth and 14-18% EBITDA growth, citing cautious optimism despite Middle East supply disruptions. A key risk is the elevated ECL provision of ₹350 crore in Q4, reflecting credit stress in Latin America. Management also announced a reorganization to unlock value in Advanta and Superform, though some investors raised concerns about shareholder dilution.

Key Numbers

Contribution Margin (Crop Protection) 31.5%
+250bps YoY

Improved due to supply chain efficiencies and better product mix.

Net Debt / EBITDA 1.6x
-0.5x YoY

Reduced from 2.1x, reflecting strong deleveraging and cash generation.

New Product Revenue (Crop Protection) $160M
+23% YoY

Exceeded target of $130M; 4% of total revenue from launches.

Specialty Chemicals Share (Superform) 28%
+8pp YoY

Mix shift from 20% to 28%, driving margin expansion in Superform.

Management Guidance

G

Q1 FY27 Revenue Growth 10-14%

Management guided Q1 FY27 revenue growth of 10-14% YoY, driven by volume and price, with FX tailwind of 7-9%.

Management guidance revenue
G

Q1 FY27 EBITDA Growth 14-18%

EBITDA growth guided at 14-18% for Q1 FY27, reflecting operating leverage despite seasonally low quarter.

Management guidance margins
G

Capex Guidance $300-350M for FY27

Capex expected to increase to $300-350 million from $261 million in FY26, focused on specialty chemicals and backward integration.

Management guidance capex
G

Net Debt/EBITDA Target 1.2-1.5x Medium Term

Target leverage ratio of 1.2-1.5x in the medium term, with current at 1.6x; will maintain optimal capital structure.

Management guidance other

Key Risks

R

Middle East Supply Chain Disruption

Geopolitical tensions could increase raw material costs and working capital needs; management is managing via disciplined sourcing and pricing.

high · management_commentary
R

Elevated Credit Loss Provisions in LatAm

Q4 ECL provision of ₹350 crore (full year ₹750 crore) reflects credit stress in Latin America; analyst questioned if this is the new normal.

medium · analyst_question
R

Shareholder Dilution from Reorganization

Analyst raised concern that the proposed demerger structure could trigger a conglomerate discount and dilute existing shareholders.

medium · analyst_question
R

Fertilizer Price Impact on Farmer Economics

Higher fertilizer costs may reduce farmer incomes and potentially lower agrochemical consumption, though management expects crop protection demand to hold.

medium · analyst_question

Notable Quotes

We are cautiously optimistic about Q1. We are already 40 days in this quarter. We have some visibility about our Q1 results.
Bikash Prasad · Group CFO, UPL Limited
We don't believe in speculations and therefore we should be able to pass on whatever the cost increase has been there.
Jai Shroff · Chairman and Group CEO, UPL Limited
Our strategy is very clear. We are focused on driving strong organic growth while continuing to gain market share across all of our core markets.
Mike Frank · CEO, UPL Corp

Frequently Asked Questions

What was UPL's revenue in Q4 FY26?

UPL reported revenue of ₹18,335 Cr in Q4 FY26, representing a +11% change compared to the same quarter last year.

What guidance did UPL management give for FY27?

Q1 FY27 Revenue Growth 10-14%: Management guided Q1 FY27 revenue growth of 10-14% YoY, driven by volume and price, with FX tailwind of 7-9%. Q1 FY27 EBITDA Growth 14-18%: EBITDA growth guided at 14-18% for Q1 FY27, reflecting operating leverage despite seasonally low quarter. Capex Guidance $300-350M for FY27: Capex expected to increase to $300-350 million from $261 million in FY26, focused on specialty chemicals and backward integration. Net Debt/EBITDA Target 1.2-1.5x Medium Term: Target leverage ratio of 1.2-1.5x in the medium term, with current at 1.6x; will maintain optimal capital structure.

What are the key risks for UPL in FY27?

Key risks include Middle East Supply Chain Disruption — Geopolitical tensions could increase raw material costs and working capital needs; management is managing via disciplined sourcing and pricing.; Elevated Credit Loss Provisions in LatAm — Q4 ECL provision of ₹350 crore (full year ₹750 crore) reflects credit stress in Latin America; analyst questioned if this is the new normal.; Shareholder Dilution from Reorganization — Analyst raised concern that the proposed demerger structure could trigger a conglomerate discount and dilute existing shareholders.; Fertilizer Price Impact on Farmer Economics — Higher fertilizer costs may reduce farmer incomes and potentially lower agrochemical consumption, though management expects crop protection demand to hold..

Did UPL meet its previous quarter's guidance?

Scorecard data is being built as historical quarters are processed.

Where can I read the full UPL Q4 FY26 concall transcript?

The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary verified against official BSE/NSE filings.